Skip to main content
Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease
Movement Disorders (2006)
  • Kelly L. Sullivan, University of South Florida
  • Joseph S. Staffetti, University of South Florida
  • Robert A. Hauser, University of South Florida
  • Peter B. Dunne, University of South Florida
  • Theresa A. Zesiewicz, University of South Florida
We performed a double‐blind randomized placebo‐controlled pilot study to determine the efficacy of tegaserod (Zelnorm) in treating constipation in 15 patients with Parkinson's disease (PD). There was a trend for improvement in the Subject's Global Assessment (SGA) of satisfaction with bowel habits (NS) and the total SGA (including abdominal discomfort, bothersome constipation, and satisfaction; NS).
  • Tegaerod,
  • Zelnorm,
  • Parkinson's Disease
Publication Date
January 21, 2006
Citation Information
Kelly L. Sullivan, Joseph S. Staffetti, Robert A. Hauser, Peter B. Dunne, et al.. "Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease" Movement Disorders Vol. 21 Iss. 1 (2006) p. 115 - 116 ISSN: 1531-8257
Available at: